Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06428721 · ClinicalTrials.gov registry record · NA

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

A NA study of Aging and Actinic Keratoses, sponsored by Wright State University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06428721 is a NA study of Aging and Actinic Keratoses that is actively recruiting participants, run by Wright State University. The registered enrollment target is 80 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06428721, a NA study of Aging and Actinic Keratoses, is actively recruiting participants, sponsored by Wright State University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if the Fractionated Laser Resurfacing (FLR) procedure can protect one forearm/wrist from precancerous actinic keratosis (AKs) as well as prevent skin cancer in older subjects with active AKs. This study builds on a similar study ongoing at the Dayton Veterans Administration dermatology clinic. This study is also testing if a photograph of the skin can be used to predict where the AKs and an skin cancers will form.

Interventions

  • DEVICE Fractionated Laser Resurfacing

Study Locations (1)

Ohio

  • Wright State Physicians - Fairborn

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-03-20
Est. Completion 2031-12
Phase NA

Sponsor

Wright State University

32 total trials

What the Registry Record Tells You About NCT06428721

The ClinicalTrials.gov registry entry for NCT06428721 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The listed sponsor is Wright State University, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Fractionated Laser Resurfacing is the first listed.

NCT06428721 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06428721 about?

NCT06428721 is a clinical study titled "The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population". The purpose of this study is to determine if the Fractionated Laser Resurfacing (FLR) procedure can protect one forearm/wrist from precancerous actinic keratosis (AKs) as well as prevent skin cancer in older subjects with active AKs. This study builds on a similar study ongoing at the Dayton Veteran...

What is the current status of trial NCT06428721?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-03-20. Estimated completion is 2031-12.

What conditions does trial NCT06428721 study?

This clinical trial studies the following conditions: Aging, Actinic Keratoses, Non-Melanoma Skin Cancer.

What interventions are being tested in trial NCT06428721?

The interventions under investigation include: Fractionated Laser Resurfacing (DEVICE).

Who is sponsoring clinical trial NCT06428721?

This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06428721 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.